150 related articles for article (PubMed ID: 3995397)
1. [Anesthesiologic management of the patient threatened by malignant hyperthermia].
Scholtes JL; Gribomont BF
Cah Anesthesiol; 1985 Mar; 33(2):159-60. PubMed ID: 3995397
[No Abstract] [Full Text] [Related]
2. Malignant hyperthermia in a liver transplant patient: a case report.
Fernandes CR; Azevedo DM; Gomes JM; Gonçalves BP; Coelho GR; Vasconcelos JB; Garcia JH
Transplant Proc; 2007 Dec; 39(10):3530-2. PubMed ID: 18089429
[TBL] [Abstract][Full Text] [Related]
3. Be prepared: malignant hyperthermia.
DeJohn P
OR Manager; 2008 Jun; 24(6):26-7, 30. PubMed ID: 18655686
[No Abstract] [Full Text] [Related]
4. Malignant hyperthermia in the otology patient: the UCLA experience.
Wackym PA; Blackwell KE
Am J Otol; 1994 May; 15(3):371-5. PubMed ID: 8579142
[TBL] [Abstract][Full Text] [Related]
5. [Prophylactic use of oral dantrolene for spinal anesthesia in a patient with susceptible malignant hyperthermia].
Shindoh M; Enomoto K; Tatekawa S; Yukioka H; Yoshimoto N; Fujimori M
Masui; 1988 Jul; 37(7):861-7. PubMed ID: 3230633
[No Abstract] [Full Text] [Related]
6. Rapid intervention for an episode of malignant hyperthermia.
Chartrand D
Can J Anaesth; 2003 Feb; 50(2):104-7. PubMed ID: 12560297
[No Abstract] [Full Text] [Related]
7. Malignant hyperthermia in the absence of triggering agents.
Setzer-Saade N
Anesth Analg; 2010 Sep; 111(3):822; author reply 822-3. PubMed ID: 20733170
[No Abstract] [Full Text] [Related]
8. Prophylactic use of dantrolene in a patient with central core disease.
Michalek-Sauberer A; Gilly H
Anesth Analg; 1998 Apr; 86(4):915-6. PubMed ID: 9539627
[No Abstract] [Full Text] [Related]
9. Mixing and using dantrolene for simulated malignant hyperthermia crisis.
Corvetto MA; Montaña R; Bravo MP; Altermatt FR
Acta Anaesthesiol Scand; 2012 Nov; 56(10):1337-8. PubMed ID: 22881345
[No Abstract] [Full Text] [Related]
10. Dantrolene sodium in the management of patients at risk from malignant hyperthermia.
Bronstein SL; Ryan DE; Solomons CC; Mahowald MC
J Oral Surg; 1979 Oct; 37(10):719-24. PubMed ID: 289734
[TBL] [Abstract][Full Text] [Related]
11. Is a formal statistical analysis always necessary?
Woehlck H
Anesth Analg; 2011 Jun; 112(6):1268-9. PubMed ID: 21613193
[No Abstract] [Full Text] [Related]
12. Malignant hyperthermia in a young adolescent: A case report.
Toh H; Shahani JM; Ali AJ
Natl Med J India; 2014; 27(5):259-60. PubMed ID: 26037425
[TBL] [Abstract][Full Text] [Related]
13. Malignant hyperthermia in a young adolescent in Singapore.
Sridhar GR
Natl Med J India; 2015; 28(2):106-7. PubMed ID: 26612166
[No Abstract] [Full Text] [Related]
14. [A case of malignant hyperthermia without hyperthermia].
Muiños PA; Ortells MA; Sánchez G; Carrasco MS
Rev Esp Anestesiol Reanim; 1995 Dec; 42(10):436. PubMed ID: 8789530
[No Abstract] [Full Text] [Related]
15. [The use of subarachnoid bupivacaine analgesia in malignant hyperthermia-susceptible subjects. A clinical case report].
Abballe C; Primieri P; De Cosmo G
Minerva Anestesiol; 1993 Jun; 59(6):335-8. PubMed ID: 8414095
[TBL] [Abstract][Full Text] [Related]
16. Malignant hyperthermia. It could happen to you.
Wraith A
SAAD Dig; 1996 Jul; 13(3):14-7. PubMed ID: 9477918
[No Abstract] [Full Text] [Related]
17. Successful treatment of intraoperative malignant hyperthermia during renal transplantation.
Goss JA; Brennan DC; Miller BT; Shenoy S; McClure S; Howard TK; Flye MW
Clin Transplant; 1996 Apr; 10(2):195-8. PubMed ID: 8664518
[TBL] [Abstract][Full Text] [Related]
18. Pre-anaesthetic administration of dantrolene sodium to a patient at risk from malignant hyperthermia: case report.
Free CW; Jaimon MP
N Z Med J; 1978 Dec; 88(626):493-4. PubMed ID: 283330
[TBL] [Abstract][Full Text] [Related]
19. Oral dantrolene.
Allen GC
Anaesthesia; 2004 Nov; 59(11):1139; author reply 1139-40. PubMed ID: 15479327
[No Abstract] [Full Text] [Related]
20. Authors' reply.
Han T
Natl Med J India; 2015; 28(2):107. PubMed ID: 26612167
[No Abstract] [Full Text] [Related]
[Next] [New Search]
